51862-535-16 : NDC 2025 Code

51862-535-16 : Brompheniramine Maleate, Pseudoephedrine Hydrochloride And Dextromethorphan Hydrobromide ( Brompheniramine Maleate, Pseudoephedrine Hydrochloride And Dextromethorphan Hydrobromide )

Additionally :

You can get information about “51862-535-16” NDC code in 51862-535-16 in HTML format

HTML | 51862-535-16 in TXT (Plain Text) format

TXT | 51862-535-16 in PDF (Portable Document Format)

PDF | 51862-535-16 in XML format

XML formats.

NDC Code : 51862-535-16 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "51862-535-16",
    "PackageDescription": "473 mL in 1 BOTTLE, PLASTIC (51862-535-16) ",
    "NDC11Code": "51862-0535-16",
    "ProductNDC": "51862-535",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Brompheniramine Maleate, Pseudoephedrine Hydrochloride And Dextromethorphan Hydrobromide",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Brompheniramine Maleate, Pseudoephedrine Hydrochloride And Dextromethorphan Hydrobromide",
    "DosageFormName": "SYRUP",
    "RouteName": "ORAL",
    "StartMarketingDate": "20190206",
    "EndMarketingDate": "20220831",
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA207676",
    "LabelerName": "Mayne Pharma",
    "SubstanceName": "BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE",
    "StrengthNumber": "2; 10; 30",
    "StrengthUnit": "mg/5mL; mg/5mL; mg/5mL",
    "Pharm_Classes": "Adrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]",
    "DEASchedule": null,
    "Status": "Deprecated",
    "LastUpdate": "2022-09-01",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": null,
    "StartMarketingDatePackage": "20190206",
    "EndMarketingDatePackage": "20220831",
    "SamplePackage": "N"
  }
}